MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

Search

SIGA Technologies Inc

Cerrado

SectorSalud

8.29 0.73

Resumen

Variación precio

24h

Actual

Mínimo

8.17

Máximo

8.38

Métricas clave

By Trading Economics

Ingresos

36M

35M

Ventas

74M

81M

P/B

Media del Sector

7.219

37.257

Margen de beneficio

43.741

Empleados

46

EBITDA

50M

47M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+15.57% upside

Dividendos

By Dow Jones

Próximas Ganancias

6 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

114M

589M

Apertura anterior

7.56

Cierre anterior

8.29

Noticias sobre sentimiento de mercado

By Acuity

24%

76%

56 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

SIGA Technologies Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

13 oct 2025, 21:45 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million -- Update

13 oct 2025, 21:07 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million

13 oct 2025, 17:03 UTC

Principales Movimientos del Mercado

Canaan ADRs Climb on Launch of Gas-to-Computing Pilot in Canada

13 oct 2025, 23:53 UTC

Charlas de Mercado

Gold Rises, Buoyed by Bullish Fundamental Backdrop -- Market Talk

13 oct 2025, 23:39 UTC

Charlas de Mercado

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

13 oct 2025, 22:15 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 22:15 UTC

Charlas de Mercado

Precinct Properties NZ's Equity Raising Looks Opportunistic -- Market Talk

13 oct 2025, 21:57 UTC

Adquisiciones, fusiones, absorciones

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct 2025, 21:36 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 21:36 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

13 oct 2025, 21:36 UTC

Charlas de Mercado

Fletcher's Near-Term Headwinds Don't Cloud Earnings Opportunity -- Market Talk

13 oct 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965M -- Update

13 oct 2025, 21:06 UTC

Adquisiciones, fusiones, absorciones

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct 2025, 20:52 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965M

13 oct 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

13 oct 2025, 20:35 UTC

Adquisiciones, fusiones, absorciones

Goldman Expects to Close Deal in 1Q

13 oct 2025, 20:34 UTC

Adquisiciones, fusiones, absorciones

Industry Ventures Will Be Part of Goldman's External Manager Platform, External Investing Group

13 oct 2025, 20:33 UTC

Adquisiciones, fusiones, absorciones

Industry Ventures Currently Manages $7B of Assets Under Supervision

13 oct 2025, 20:32 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs: Deal to Include Up to $300M of Additional Contingent Consideration Based on Future Performance Through 2030

13 oct 2025, 20:31 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs: Consideration to Include $665M Cash and Equity Payable at Closing

13 oct 2025, 20:29 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Buy VC Firm Industry Ventures

13 oct 2025, 19:05 UTC

Charlas de Mercado

Oil Futures Pick Up on Easing U.S.-China Tension -- Market Talk

13 oct 2025, 18:59 UTC

Charlas de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

13 oct 2025, 18:26 UTC

Charlas de Mercado

Precious Metals Close at New Record Highs -- Market Talk

13 oct 2025, 18:10 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 18:10 UTC

Charlas de Mercado

Broadcom's OpenAI Deal Highlights AI Opportunity -- Market Talk

13 oct 2025, 17:05 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 17:05 UTC

Charlas de Mercado

OpenAI Deal Offers Huge Upside to Broadcom's Earnings -- Market Talk

13 oct 2025, 16:03 UTC

Adquisiciones, fusiones, absorciones

Umicore Completes Sale, Subsequent Lease-in of Permanent Gold Inventories

13 oct 2025, 15:35 UTC

Charlas de Mercado

Precious Metals Push Record Highs Further -- Market Talk

Comparación entre iguales

Cambio de precio

SIGA Technologies Inc Esperado

Precio Objetivo

By TipRanks

15.57% repunte

Estimación a 12 meses

Media 9.5 USD  15.57%

Máximo 9.5 USD

Mínimo 9.5 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para SIGA Technologies Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

1

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

5.41 / 5.63Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

56 / 371 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de SIGA Technologies Inc

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
help-icon Live chat